Diseases, Conditions, Syndromes

Mavyret approved as 8-week treatment for hep C, compensated cirrhosis

(HealthDay)—Approval of Mavyret (glecaprevir and pibrentasvir) tablets has been expanded to eight-week treatment for treatment-naive patients aged 12 years and older with chronic hepatitis C virus (HCV) genotypes 1 through ...

Diseases, Conditions, Syndromes

Sofosbuvir improves renal safety in patients with chronic hep C

(HealthDay)—Sofosbuvir-based treatment appears to guarantee renal safety for patients with chronic hepatitis C virus over one year of follow-up, according to a study published online May 7 in the Journal of Clinical Pharmacy ...

Diseases, Conditions, Syndromes

Respiratory virus lurks as wintertime worry

(HealthDay)—A common respiratory virus that circulates in winter can pose a serious threat to children, an expert warns.

HIV & AIDS

Rapid, successful response to ART for many patients with HIV

(HealthDay)—Many HIV-infected patients have rapid and successful immune and virological response to antiretroviral therapy (ART), according to a study published online Sept. 27 in the Journal of Clinical Pharmacy and Therapeutics.

Medical research

No two kinds of retroviruses look—or act—the same

In the most comprehensive study of its kind, researchers in the Institute for Molecular Virology and School of Dentistry at the University of Minnesota report that most types of retroviruses have distinct, non-identical virus ...

Oncology & Cancer

SPF30 sunscreens delay melanoma incidence in preclinical model

Application of sun protection factor 30 (SPF30) sunscreen prior to exposure to ultraviolet-B (UVB) light delayed melanoma onset in a mouse model of the disease, according to data from a team at The Ohio State University Comprehensive ...

page 1 from 17